why choose us

First received: January 15, 2023

Clinical Trial: Tissue-resident Memory T Cells Expression in Melasma

Study Status: Completed

Recruit Status: Completed

Condition: Melasma

Study Type: Observational


Official Title: Tissue-resident Memory T Cells Expression in Melasma

Brief Summary: The treatment of melasma and the maintenance of depigmentation represent a challenge due to its frequent recurrences. Pathophysiological mechanisms and factors have been linked to melasma such as inflammation, sun exposure, increased CD4+ T lymphocytic infiltrate and IL-17 in damaged skin. Tissue-resident memory T cells (Trm), derived from naïve T lymphocytes, are associated with the recurrence of lesions at the same sites but they have not been described in melasma. This a Cross-sectional, prospective analytical…

Read more